BioCardia (BCDA) 10-Q2024 Q3 Quarterly report

Filed: 13 Nov 24, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: AccessPro, aim, algorithm, animal, begun, behavior, Biopharmaceutical, burdensome, buy, capillary, care, Cautionary, closer, consent, consented, copy, Core, CPA, decline, degree, density, discharged, discover, dosage, dysfunction, Europe, fiscal, fundraising, greatest, growth, guideline, Hawthorne, history, implied, independent, inflammatory, jointly, line, lose, low, mechanism, microvascular, omitted, overnight, par, personalized, placebo, preprocedural, profit, profitability, profitable, promote, refine, relationship, repair, respond, retroactively, short, signature, source, speculative, standard, strong, succeed, supplementary, sustain, thereto, titled, top, universal, University, verification, vi, window, Wisconsin

Removed: academic, activated, adaptive, advancing, assessment, attempt, bone, broader, conform, decision, deposit, enabling, enrolling, experienced, fact, foregoing, identifying, import, initial, lab, marrow, office, prior, pro, project, publicly, remit, secondary, today, training

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated BCDA transcripts

BCDA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification of Principal Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, David McClung, the Chief Financial Officer of BioCardia, Inc. (the “Company”), hereby certify, that, to my knowledge:

1. The Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 13, 2024

/s/ David McClung

Name: David McClung

Title: Chief Financial Officer

(Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.